[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/18, WED) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)

 J&J, 올린 33.25억弗 인수.."VEGFxAng-2 항체 확보"
[https://www.biospectator.com/news/view/30430](https://www.biospectator.com/news/view/30430)

 릴리, 칼리트릭스 15억弗 인수.."mCALR 이중항체 개발" 
[https://www.biospectator.com/news/view/30431](https://www.biospectator.com/news/view/30431)

 대웅제약, 'JAK3xITKxBTK 삼중저해제' 1상 "ACR 발표" 
[https://www.biospectator.com/news/view/30435](https://www.biospectator.com/news/view/30435)

 한미약품, 'EZH1/2 이중저해제' 최신 1상 "업데이트" 
[https://www.biospectator.com/news/view/30437](https://www.biospectator.com/news/view/30437)

 동아ST-메타비아, 'GLP-1/GCG' vs삼중작용제 전임상 발표
[https://www.biospectator.com/news/view/30440](https://www.biospectator.com/news/view/30440)

 휴온스, '경구 MC4R 작용제' 비임상 "美비만학회 발표"
[https://www.biospectator.com/news/view/30433](https://www.biospectator.com/news/view/30433)

 베리스모, 美스탠퍼드 의대서 '인비보 CAR-T' 기술 도입 
[https://www.biospectator.com/news/view/30446](https://www.biospectator.com/news/view/30446)

 릴리, 스티플과 '암특이 에피토프' 바인더 발굴 59억弗 딜
[https://www.biospectator.com/news/view/30449](https://www.biospectator.com/news/view/30449)

 신라젠, '항암바이러스' 후보물질 "KDDF 과제선정" 
[https://www.biospectator.com/news/view/30451](https://www.biospectator.com/news/view/30451)

 큐리언트, ‘이중페이로드’ HER2 ADC "KDDF 과제선정“
[https://www.biospectator.com/news/view/30455](https://www.biospectator.com/news/view/30455)
 
 롯데바이오로직스, 송도 바이오캠퍼스 준공식 개최 
[https://www.biospectator.com/news/view/30457](https://www.biospectator.com/news/view/30457)

[#바이오스펙테이터](?q=%23%EB%B0%94%EC%9D%B4%EC%98%A4%EC%8A%A4%ED%8E%99%ED%85%8C%EC%9D%B4%ED%84%B0) [#전일](?q=%23%EC%A0%84%EC%9D%BC)(11/18, WED) [#전체기사](?q=%23%EC%A0%84%EC%B2%B4%EA%B8%B0%EC%82%AC)